Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth

Fertility and Sterility

Volumn 104, Issue 2, 2015, Pages 325-332

  Nelson, Scott M ^a   Fleming, Richard ^a,b   Gaudoin, Marco ^b   Choi, Bokyung ^c   Santo Domingo, Kenny ^c   Yao, Mylene ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Glasgow Centre for Reproductive Medicine   (United Kingdom)

^c Univfy Inc   (United States)

Author keywords

Antim llerian hormone; antral follicle count; live birth; prediction model

Indexed keywords

MUELLERIAN INHIBITING FACTOR; BIOLOGICAL MARKER;

ADULT; ANALYSIS; ANTRAL FOLLICLE COUNT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; FEMALE GENITAL TRACT PARAMETERS; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; OVARIAN RESERVE; OVARIAN STIMULATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RECLASSIFICATION ANALYSIS; BIOLOGICAL MODEL; BLOOD; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; METABOLISM; OVARY FOLLICLE; OVULATION INDUCTION; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PREGNANCY; PROCEDURES; RETROSPECTIVE STUDY; TRENDS;

ANTI-MULLERIAN HORMONE; BIOMARKERS; COHORT STUDIES; FEMALE; HUMANS; LIVE BIRTH; MODELS, BIOLOGICAL; OVARIAN FOLLICLE; OVULATION INDUCTION; PRECISION MEDICINE; PREDICTIVE VALUE OF TESTS; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 84938292021     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.04.032     Document Type: Article

References (41)

1. S.M. Nelson, and D.A. Lawlor Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles PLoS Med 8 2011 e1000386
2. P. Banerjee, B. Choi, L.K. Shahine, S.H. Jun, K. O'Leary, R.B. Lathi, and et al. Deep phenotyping to predict live birth outcomes in in vitro fertilization Proc Natl Acad Sci U S A 107 2010 13570 13575
3. NICE. Fertility guideline: Chapter 14 and Appendix M. Available at: http://www.niceorguk/ 2013.
4. E.R. te Velde, D. Nieboer, A.M. Lintsen, D.D. Braat, M.J. Eijkemans, J.D. Habbema, and et al. Comparison of two models predicting IVF success; the effect of time trends on model performance Hum Reprod 29 2014 57 64
5. B. Choi, E. Bosch, B.M. Lannon, M.-C. Leveille, W.H. Wong, A. Leader, and et al. Personalized prediction of first-cycle in vitro fertilization success Fertil Steril 99 2013 1905 1911
6. P. Arvis, P. Lehert, and A. Guivarc'h-Levêque Simple adaptations to the Templeton model for IVF outcome prediction make it current and clinically useful Hum Reprod 27 2012 2971 2978
7. L. van Loendersloot, S. Repping, P.M. Bossuyt, F. van der Veen, and M. van Wely Prediction models in in vitro fertilization; where are we? A mini review J Adv Res 5 2014 295 301
8. E. Leushuis, J.W. van der Steeg, P. Steures, P.M.M. Bossuyt, M.J.C. Eijkemans, F. van der Veen, and et al. Prediction models in reproductive medicine: a critical appraisal Hum Reprod Update 15 2009 537 552
9. B. Luke, M.B. Brown, E. Wantman, J.E. Stern, V.L. Baker, E. Widra, and et al. A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology Fertil Steril 102 2014 744 752
10. S. Iliodromiti, R.A. Anderson, and S.M. Nelson Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response Hum Reprod Update 2014 Dec 8 pii: dmu062. [Epub ahead of print]
11. J. Holte, T. Brodin, L. Berglund, N. Hadziosmanovic, M. Olovsson, and T. Bergh Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries Fertil Steril 96 2011 594 599
12. S. Iliodromiti, T.W. Kelsey, O. Wu, R.A. Anderson, and S.M. Nelson The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature Hum Reprod Update 20 2014 560 570
13. A. La Marca, S.M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L. Roli, and et al. Anti-Mullerian Hormone (AMH) based prediction model for the live birth in assisted reproductive technology (ART) Reprod Biomed Online 22 2011 341 349
14. A. Khader, S. Lloyd, A. McConnachie, R. Fleming, V. Grisendi, A. La Marca, and et al. External validation of anti-Mullerian hormone based prediction of live birth in assisted conception J Ovarian Res 6 2013 3
15. S.M. Nelson, B.M. Klein, and J.C. Arce Comparison of antimullerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials Fertil Steril 103 2015 923 930
16. A.N. Andersen, H. Witjes, K. Gordon, and B. Mannaerts Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment Hum Reprod 26 2011 3413 3423
17. B.M. Lannon, B. Choi, M.R. Hacker, L.E. Dodge, B.A. Malizia, C.B. Barrett, and et al. Predicting personalized multiple birth risks after in vitro fertilization-double embryo transfer Fertil Steril 98 2012 69 76
18. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy Hum Reprod 22 2007 2414 2421
19. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, and et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
20. D.A. Lawlor, and S.M. Nelson Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study Lancet 379 2012 521 527
21. F.J. Broekmans, D. de Ziegler, C.M. Howles, A. Gougeon, G. Trew, and F. Olivennes The antral follicle count: practical recommendations for better standardization Fertil Steril 94 2010 1044 1051
22. S.M. Nelson, M.C. Messow, A.M. Wallace, R. Fleming, and A. McConnachie Nomogram for the decline in serum antimullerian hormone: a population study of 9,601 infertility patients Fertil Steril 95 2011 736 741.e1-3
23. S.M. Nelson, M.C. Messow, A. McConnachie, H. Wallace, T. Kelsey, R. Fleming, and et al. External validation of nomogram for the decline in serum anti-Mullerian hormone in women: a population study of 15,834 infertility patients Reprod Biomed Online 23 2011 204 206
24. S.M. Nelson, S. Iliodromiti, R. Fleming, R. Anderson, A. McConnachie, and C.M. Messow Reference range for the antimullerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram Fertil Steril 101 2014 523 529
25. S.M. Nelson, and A. La Marca The journey from the old to the new AMH assay: how to avoid getting lost in the values Reprod Biomed Online 23 2011 411 420
26. A.M. Wallace, S.A. Faye, R. Fleming, and S.M. Nelson A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II) Ann Clin Biochem 48 2011 370 373
27. J.H. Friedman Stochastic gradient boosting Comput Stat Data An 38 2002 367 378
28. J.H. Friedman Greedy function approximation: a gradient boosting machine Ann Stat 29 2001 1189-32
29. Ridgeway G. gbm: generalized boosted regression models. R package, Ver. 16-3. 2007. Available at: http://cran.r-project.org/web/packages/gbm/. Accessed August 6, 2014.
30. S.K. Sunkara, V. Rittenberg, N. Raine-Fenning, S. Bhattacharya, J. Zamora, and A. Coomarasamy Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum Reprod 26 2011 1768 1774
31. J.C. Arce, A. La Marca, B. Mirner Klein, A. Nyboe Andersen, and R. Fleming Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients Fertil Steril 99 2013 1644 1653
32. A. Maheshwari, L. Stofberg, and S. Bhattacharya Effect of overweight and obesity on assisted reproductive technology a systematic review Hum Reprod Update 13 2007 433 444
33. E.S. Jungheim, S.B. Schon, M.B. Schulte, D.A. DeUgarte, S.A. Fowler, and M.G. Tuuli IVF outcomes in obese donor oocyte recipients: a systematic review and meta-analysis Hum Reprod 28 2013 2720 2727
34. E.L. Anderson, A. Fraser, W. McNally, N. Sattar, H. Lashen, R. Fleming, and et al. Anti-mullerian hormone is not associated with cardiometabolic risk factors in adolescent females PLoS One 8 2013 e64510
35. M. Dolleman, W. Verschuren, M. Eijkemans, M. Dollé, E. Jansen, F. Broekmans, and et al. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study J Clin Endocrinol Metab 98 2013 2106 2115
36. S.L. Broer, J. van Disseldorp, K.A. Broeze, M. Dolleman, B.C. Opmeer, P. Bossuyt, and et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach Hum Reprod Update 19 2013 26 36
37. S.L. Broer, M. Dólleman, J. van Disseldorp, K.A. Broeze, B.C. Opmeer, P.M.M. Bossuyt, and et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis Fertil Steril 100 2013 420 429.e7
38. J.V. Jeppesen, R.A. Anderson, T.W. Kelsey, S.L. Christiansen, S.G. Kristensen, K. Jayaprakasan, and et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection Mol Hum Reprod 19 2013 519 527
39. K. Jayaprakasan, S. Deb, M. Batcha, J. Hopkisson, I. Johnson, B. Campbell, and et al. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mullerian hormone and response to controlled ovarian stimulation Fertil Steril 94 2010 1775 1781
40. E.W. Steyerberg, K.G. Moons, D.A. van der Windt, J.A. Hayden, P. Perel, S. Schroter, and et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research PLoS Med 10 2013 e1001381
41. D. Gassner, and R. Jung First fully automated immunoassay for anti-Mullerian hormone Clin Chem Lab Med 52 2014 1143 1152